REGENXBIO's GAAP loss for 2020 was $111.25 million, up 17.4% from $94.733 million the previous year. Revenue increased 4.4 times to $154.567 million from $35.233 million a year earlier.
REGENXBIO's GAAP loss for 2020 was $111.25 million, up 17.4% from $94.733 million the previous year. Revenue increased 4.4 times to $154.567 million from $35.233 million a year earlier. 
regenxbio.gcs-web.com
English (US) 